IMAC (BACK) Competitors

Aclarion (NASDAQ:ACON) and IMAC (NASDAQ:BACK) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, community ranking, profitability, earnings, dividends and risk.

Do insiders and institutionals believe in ACON or BACK?

7.5% of Aclarion shares are held by institutional investors. Comparatively, 5.8% of IMAC shares are held by institutional investors. 0.8% of Aclarion shares are held by company insiders. Comparatively, 12.3% of IMAC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Which has more risk and volatility, ACON or BACK?

Aclarion has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, IMAC has a beta of 0.16, indicating that its stock price is 84% less volatile than the S&P 500.

Does the media prefer ACON or BACK?

In the previous week, Aclarion had 3 more articles in the media than IMAC. MarketBeat recorded 7 mentions for Aclarion and 4 mentions for IMAC. IMAC's average media sentiment score of 0.51 beat Aclarion's score of 0.27 indicating that IMAC is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aclarion	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
IMAC	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer ACON or BACK?

Aclarion received 4 more outperform votes than IMAC when rated by MarketBeat users. Likewise, 80.00% of users gave Aclarion an outperform vote while only 0.00% of users gave IMAC an outperform vote.

Company	Underperform	Outperform
Aclarion	Outperform Votes 4 80.00%	Underperform Votes 1 20.00%
IMAC	Outperform Votes No Votes	Underperform Votes 1 100.00%

Which has preferable earnings & valuation, ACON or BACK?

Aclarion has higher earnings, but lower revenue than IMAC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$49.29K	125.16	-$4.91M	N/A	N/A
IMAC	$72.05K	1.50	-$9.42M	N/A	N/A

Is ACON or BACK more profitable?

IMAC has a net margin of 0.00% compared to Aclarion's net margin of -12,845.05%. IMAC's return on equity of 0.00% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	-12,845.05%	-422.87%	-201.15%
IMAC	N/A	N/A	-325.44%

Do analysts prefer ACON or BACK?

Aclarion currently has a consensus target price of $435.50, suggesting a potential upside of 3,493.23%. Given Aclarion's stronger consensus rating and higher possible upside, analysts plainly believe Aclarion is more favorable than IMAC.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
IMAC	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Aclarion beats IMAC on 11 of the 16 factors compared between the two stocks.